HY-101042-10mg
|
MedChemexpress LLC
|
AG-494 [CAS 133550-35-3]
|
|
COVID-19-immunoregulation
|
|
HY-101042-100mg
|
MedChemexpress LLC
|
AG-494 [CAS 133550-35-3]
|
|
COVID-19-immunoregulation
|
|
HY-101042-25mg
|
MedChemexpress LLC
|
AG-494 [CAS 133550-35-3]
|
|
COVID-19-immunoregulation
|
|
HY-101042-5mg
|
MedChemexpress LLC
|
AG-494 [CAS 133550-35-3]
|
|
COVID-19-immunoregulation
|
|
HY-101042-50mg
|
MedChemexpress LLC
|
AG-494 [CAS 133550-35-3]
|
|
COVID-19-immunoregulation
|
|
HY-10291-100mg
|
MedChemexpress LLC
|
Tarenflurbil [CAS 51543-40-9]
|
|
COVID-19-immunoregulation
|
|
HY-107613A-10mg
|
MedChemexpress LLC
|
R 59-022 (hydrochloride) [CAS 93076-98-3]
|
|
COVID-19-immunoregulation
|
|
HY-107613A-25mg
|
MedChemexpress LLC
|
R 59-022 (hydrochloride) [CAS 93076-98-3]
|
|
COVID-19-immunoregulation
|
|
HY-107613A-5mg
|
MedChemexpress LLC
|
R 59-022 (hydrochloride) [CAS 93076-98-3]
|
|
COVID-19-immunoregulation
|
|
HY-107613A-50mg
|
MedChemexpress LLC
|
R 59-022 (hydrochloride) [CAS 93076-98-3]
|
|
COVID-19-immunoregulation
|
|
HY-107647A-10mg
|
MedChemexpress LLC
|
(R)-(+)-Dimethindene (maleate) [CAS 136152-64-2]
|
|
COVID-19-immunoregulation
|
|
HY-107647A-100mg
|
MedChemexpress LLC
|
(R)-(+)-Dimethindene (maleate) [CAS 136152-64-2]
|
|
COVID-19-immunoregulation
|
|
HY-107647A-25mg
|
MedChemexpress LLC
|
(R)-(+)-Dimethindene (maleate) [CAS 136152-64-2]
|
|
COVID-19-immunoregulation
|
|
HY-107647A-5mg
|
MedChemexpress LLC
|
(R)-(+)-Dimethindene (maleate) [CAS 136152-64-2]
|
|
COVID-19-immunoregulation
|
|
HY-107647A-50mg
|
MedChemexpress LLC
|
(R)-(+)-Dimethindene (maleate) [CAS 136152-64-2]
|
|
COVID-19-immunoregulation
|
|
HY-109143B-10mg
|
MedChemexpress LLC
|
(R)-Elsubrutinib [CAS 1643570-23-3]
|
|
COVID-19-immunoregulation
|
|
HY-109143B-100mg
|
MedChemexpress LLC
|
(R)-Elsubrutinib [CAS 1643570-23-3]
|
|
COVID-19-immunoregulation
|
|
HY-109143B-25mg
|
MedChemexpress LLC
|
(R)-Elsubrutinib [CAS 1643570-23-3]
|
|
COVID-19-immunoregulation
|
|
HY-109143B-5mg
|
MedChemexpress LLC
|
(R)-Elsubrutinib [CAS 1643570-23-3]
|
|
COVID-19-immunoregulation
|
|
HY-109143B-50mg
|
MedChemexpress LLC
|
(R)-Elsubrutinib [CAS 1643570-23-3]
|
|
COVID-19-immunoregulation
|
|
HY-109187B-10mg
|
MedChemexpress LLC
|
(R)-Posenacaftor (sodium) [CAS 2095064-09-6]
|
|
COVID-19-immunoregulation
|
|
HY-109187B-100mg
|
MedChemexpress LLC
|
(R)-Posenacaftor (sodium) [CAS 2095064-09-6]
|
|
COVID-19-immunoregulation
|
|
HY-109187B-25mg
|
MedChemexpress LLC
|
(R)-Posenacaftor (sodium) [CAS 2095064-09-6]
|
|
COVID-19-immunoregulation
|
|
HY-109187B-5mg
|
MedChemexpress LLC
|
(R)-Posenacaftor (sodium) [CAS 2095064-09-6]
|
|
COVID-19-immunoregulation
|
|
HY-109187B-50mg
|
MedChemexpress LLC
|
(R)-Posenacaftor (sodium) [CAS 2095064-09-6]
|
|
COVID-19-immunoregulation
|
|